(Q62040673)

English

Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Clinical Study of Redirected Autologous T Cells With a BCMA-targeted Chimeric Antigen Receptor in Patients With Refractory or Relapsed Multiple Myeloma (English)

0 references

medical condition

multiple myeloma

0 references

start time

26 December 2017

0 references

end time

30 April 2019

0 references

number of participants

12

0 references

research intervention

(RS)-cyclophosphamide

0 references

fludarabine phosphate

0 references

clinical trial phase

phase I clinical trial

0 references

research site

Zhejiang University

0 references

research subject recruitment status

recruiting

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT03716856

0 references

(Q62040673)

Clinical Study of CAR-BCMA T in Patients With Refractory or Relapsed Multiple Myeloma

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)